Ruzicka K - Search Results

1

Morning hypercoagulability and hypofibrinolysis. Diurnal variations in circulating activated factor VII, prothrombin fragment F1+2, and plasmin-plasmin inhibitor complex.

Kapiotis S, Jilma B, Quehenberger P, Ruzicka K, Handler S, Speiser W. Kapiotis S, et al. Among authors: ruzicka k. Circulation. 1997 Jul 1;96(1):19-21. doi: 10.1161/01.cir.96.1.19. Circulation. 1997. PMID: 9236409 Clinical Trial.

2

Leptin induces endothelin-1 in endothelial cells in vitro.

Quehenberger P, Exner M, Sunder-Plassmann R, Ruzicka K, Bieglmayer C, Endler G, Muellner C, Speiser W, Wagner O. Quehenberger P, et al. Among authors: ruzicka k. Circ Res. 2002 Apr 5;90(6):711-8. doi: 10.1161/01.res.0000014226.74709.90. Circ Res. 2002. PMID: 11934840

3

Evaluation of bedside prothrombin time and activated partial thromboplastin time measurement by coagulation analyzer CoaguCheck Plus in various clinical settings.

Ruzicka K, Kapiotis S, Quehenberger P, Handler S, Hornykewycz S, Michitsch A, Huber K, Clemens D, Susan M, Pabinger I, Eichinger S, Jilma B, Speiser W. Ruzicka K, et al. Thromb Res. 1997 Sep 1;87(5):431-40. doi: 10.1016/s0049-3848(97)00159-x. Thromb Res. 1997. PMID: 9306617

4

Evaluation of a new screening assay ProC Global for identification of defects in the protein C/protein S anticoagulant pathway.

Ruzicka K, Kapiotis S, Quehenberger P, Handler S, Pabinger-Fasching I, Mannhalter C, Jilma B, Speiser W. Ruzicka K, et al. Thromb Res. 1997 Sep 15;87(6):501-10. doi: 10.1016/s0049-3848(97)00179-5. Thromb Res. 1997. PMID: 9330432

5

Human endothelial cells do not exert heparin like accelerating effects on thrombin-antithrombin-complex formation.

Ruzicka K, Wojta J, Artemiou O, Birsan T, Quehenberger P, Kapiotis S, Hofbauer R, Speiser W. Ruzicka K, et al. Life Sci. 1998;63(17):1493-503. doi: 10.1016/s0024-3205(98)00416-0. Life Sci. 1998. PMID: 9808060

6

Evaluation of the automated coagulation analyzer SYSMEX CA 6000.

Quehenberger P, Kapiotis S, Handler S, Ruzicka K, Speiser W. Quehenberger P, et al. Among authors: ruzicka k. Thromb Res. 1999 Oct 1;96(1):65-71. doi: 10.1016/s0049-3848(99)00069-9. Thromb Res. 1999. PMID: 10554086

7

A common C-->T polymorphism at nt 46 in the promoter region of coagulation factor XII is associated with decreased factor XII activity.

Endler G, Exner M, Mannhalter C, Meier S, Ruzicka K, Handler S, Panzer S, Wagner O, Quehenberger P. Endler G, et al. Among authors: ruzicka k. Thromb Res. 2001 Feb 15;101(4):255-60. doi: 10.1016/s0049-3848(00)00404-7. Thromb Res. 2001. PMID: 11248286

8

Personalized antiplatelet treatment after percutaneous coronary intervention: the MADONNA study.

Siller-Matula JM, Francesconi M, Dechant C, Jilma B, Maurer G, Delle-Karth G, Gouya G, Ruzicka K, Podczeck-Schweighofer A, Christ G. Siller-Matula JM, et al. Among authors: ruzicka k. Int J Cardiol. 2013 Sep 1;167(5):2018-23. doi: 10.1016/j.ijcard.2012.05.040. Epub 2012 May 30. Int J Cardiol. 2013. PMID: 22656044 Clinical Trial.

9

The new hematology analyzer Sysmex XE-2100: performance evaluation of a novel white blood cell differential technology.

Ruzicka K, Veitl M, Thalhammer-Scherrer R, Schwarzinger I. Ruzicka K, et al. Arch Pathol Lab Med. 2001 Mar;125(3):391-6. doi: 10.5858/2001-125-0391-TNHASX. Arch Pathol Lab Med. 2001. PMID: 11231489 Free article.

10

Evaluation of four automated methods for determination of whole blood cyclosporine concentrations.

Hamwi A, Veitl M, Männer G, Ruzicka K, Schweiger C, Szekeres T. Hamwi A, et al. Among authors: ruzicka k. Am J Clin Pathol. 1999 Sep;112(3):358-65. doi: 10.1093/ajcp/112.3.358. Am J Clin Pathol. 1999. PMID: 10478141

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

84 results

Search Page

Filters